The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity
Fan Zou, Jizhou Tan, Ting Liu, Bingfeng Liu, Ya‐Ping Tang, Hui Zhang, Jiaping Li
Topics & Concepts
Cancer researchCytotoxic T cellVirologyCD8Surface proteinBiologyMolecular biologyImmunologyAntigenIn vitroBiochemistryImmune Cell Function and InteractionCAR-T cell therapy researchAdenosine and Purinergic Signaling